Avidity Biosciences, Inc. logo

Avidity Biosciences, Inc.

NASDAQ:RNA

Overview | Financials
Company Name Avidity Biosciences, Inc.
Symbol RNA
Currency USD
Price 40.46
Market Cap 4,738,715,660
Dividend Yield 0%
52-week-range 4.825 - 48.801
Industry Biotechnology
Sector Healthcare
CEO Ms. Sarah Boyce
Website https://www.aviditybiosciences.com

An error occurred while fetching data.

About Avidity Biosciences, Inc.

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle

Related Stocks

Verve Therapeutics, Inc. logo

Verve Therapeutics, Inc.

VERV

5.595 USD

HealthStream, Inc. logo

HealthStream, Inc.

HSTM

28.34 USD

Aurora Cannabis Inc. logo

Aurora Cannabis Inc.

ACB

5.41 USD

Merus N.V. logo

Merus N.V.

MRUS

50 USD

Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc.

AVIR

3.6 USD

Atai Life Sciences N.V. logo

Atai Life Sciences N.V.

ATAI

1.19 USD

InnovAge Holding Corp. logo

InnovAge Holding Corp.

INNV

6.21 USD

Nektar Therapeutics logo

Nektar Therapeutics

NKTR

1.12 USD

Codexis, Inc. logo

Codexis, Inc.

CDXS

2.74 USD

Financials

Numbers are in millions USD

Numbers are in millions USD